Number of the records: 1
antiparkinsoniká
SYS d000978 LBL 00000cz--a2200000o--4500 005 20250606213632.2 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D27.505.954.427.090.050 066 $a 01 $c 03 150 $a antiparkinsoniká $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d010276 $Y Parasympatholytics $w b $a parasympatolytiká 665 $a 76; was ANTIPARKINSON DRUGS 1972-75 (Prov 1972); was ANTIPARKINSON DRUGS see under PARASYMPATHOLYTICS 1963-72 $2 eng 665 $a Parasympatholytics (1966-1972) $2 eng 665 $a Parkinsonism/drug therapy (1966-1972) $2 eng 680 9-
$i Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. $2 eng 680 $a general or unspecified; prefer specifics $2 eng 750 -2
$a Antiparkinson Agents $2 eng 980 $x M
Number of the records: 1